Cargando…

Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients

BACKGROUND: Early diagnosis of reactivated Chagas disease in HIV patients could be lifesaving. In Latin America, the diagnosis is made by microscopical detection of the T. cruzi parasite in the blood; a diagnostic test that lacks sensitivity. This study evaluates if levels of T. cruzi antigens in ur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castro-Sesquen, Yagahira E., Gilman, Robert H., Mejia, Carolina, Clark, Daniel E., Choi, Jeong, Reimer-McAtee, Melissa J., Castro, Rosario, Valencia-Ayala, Edward, Flores, Jorge, Bowman, Natalie, Castillo-Neyra, Ricardo, Torrico, Faustino, Liotta, Lance, Bern, Caryn, Luchini, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768913/ https://www.ncbi.nlm.nih.gov/pubmed/26919324 http://dx.doi.org/10.1371/journal.pntd.0004407

Ejemplares similares

Use of a Novel Chagas Urine Nanoparticle Test (Chunap) for Diagnosis of Congenital Chagas Disease
por: Castro-Sesquen, Yagahira E., et al.
Publicado: (2014)

Detection of Soluble Antigen and DNA of Trypanosoma cruzi in Urine Is Independent of Renal Injury in the Guinea Pig Model
por: Castro-Sesquen, Yagahira E., et al.
Publicado: (2013)

Cell Death and Serum Markers of Collagen Metabolism during Cardiac Remodeling in Cavia porcellus Experimentally Infected with Trypanosoma cruzi
por: Castro-Sesquen, Yagahira E., et al.
Publicado: (2013)

Evaluation of 2 Lateral Flow Rapid Tests in the Diagnosis of Chagas Disease in the Washington Metropolitan Area
por: Castro-Sesquen, Yagahira E, et al.
Publicado: (2021)

Recommendations for Screening and Diagnosis of Chagas Disease in the United States
por: Forsyth, Colin J, et al.
Publicado: (2021)

Evaluation of Microscopic Observation Drug Susceptibility (MODS) and the string test for rapid diagnosis of pulmonary tuberculosis in HIV/AIDS patients in Bolivia
por: Lora, Meredith H., et al.
Publicado: (2015)

Trypanosoma cruzi parasitemia in chronic Chagas disease: Insights from hierarchical modeling
por: Abad-Franch, Fernando
Publicado: (2022)

Aplastic Anemia and Chagas Disease: T. cruzi Parasitemia Monitoring by Quantitative PCR and Preemptive Antiparasitic Therapy
por: Carvalho, Noêmia Barbosa, et al.
Publicado: (2022)

Improved Completion Rates and Characterization of Drug Reactions with an Intensive Chagas Disease Treatment Program in Rural Bolivia
por: Tornheim, Jeffrey A., et al.
Publicado: (2013)

Trypanosoma cruzi-Infected Pregnant Women without Vector Exposure Have Higher Parasitemia Levels: Implications for Congenital Transmission Risk
por: Rendell, Victoria R., et al.
Publicado: (2015)

1210. Recommendations for Screening and Diagnosis of Chagas Disease in the United States
por: Forsyth, Colin, et al.
Publicado: (2021)

Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease
por: Messenger, Louisa A, et al.
Publicado: (2015)

Genetic association study of NLRP1, CARD, and CASP1 inflammasome genes with chronic Chagas cardiomyopathy among Trypanosoma cruzi seropositive patients in Bolivia
por: Clipman, Steven J., et al.
Publicado: (2018)

Periurban Trypanosoma cruzi–infected Triatoma infestans, Arequipa, Peru
por: Levy, Michael Zachary, et al.
Publicado: (2006)

Human Trypanosoma cruzi chronic infection leads to individual level steady-state parasitemia: Implications for drug-trial optimization in Chagas disease
por: De Salazar, Pablo M., et al.
Publicado: (2022)

Immunologic changes are detectable in the peripheral blood transcriptome of clinically asymptomatic Chagas cardiomyopathy patients
por: Duque, Carolina, et al.
Publicado: (2023)

Chagas Disease in People with HIV: A Narrative Review
por: Clark, Eva H., et al.
Publicado: (2021)

Retracing Micro-Epidemics of Chagas Disease Using Epicenter Regression
por: Levy, Michael Z., et al.
Publicado: (2011)

Use of multiple urinary biomarkers for the early detection of chronic kidney disease in sickle cell anemia
por: Castro-Sesquen, Yagahira E., et al.
Publicado: (2023)

The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas
por: Ricci, Alejandro D., et al.
Publicado: (2023)

Trypanosoma cruzi IIc: Phylogenetic and Phylogeographic Insights from Sequence and Microsatellite Analysis and Potential Impact on Emergent Chagas Disease
por: Llewellyn, Martin S., et al.
Publicado: (2009)

Targeted Screening Strategies to Detect Trypanosoma cruzi Infection in Children
por: Levy, Michael Z., et al.
Publicado: (2007)

A tribute to Cecilio Romaña: Romaña’s sign in Chagas disease
por: Beucler, Nathan, et al.
Publicado: (2020)

Chagas Disease, Migration and Community Settlement Patterns in Arequipa, Peru
por: Bayer, Angela M., et al.
Publicado: (2009)

Maternal Infection with Trypanosoma cruzi and Congenital Chagas Disease Induce a Trend to a Type 1 Polarization of Infant Immune Responses to Vaccines
por: Dauby, Nicolas, et al.
Publicado: (2009)

A Field Trial of Alternative Targeted Screening Strategies for Chagas Disease in Arequipa, Peru
por: Hunter, Gabrielle C., et al.
Publicado: (2012)

Highly diluted medication reduces parasitemia and improves experimental infection evolution by Trypanosoma cruzi
por: Aleixo, Denise Lessa, et al.
Publicado: (2012)

CD4(+)CD25(+)FOXP3(+) Treg Cells Induced by rSSP4 Derived from T. cruzi Amastigotes Increase Parasitemia in an Experimental Chagas Disease Model
por: Flores-García, Y., et al.
Publicado: (2013)

Deep serological profiling of the Trypanosoma cruzi TSSA antigen reveals different epitopes and modes of recognition by Chagas disease patients
por: Romer, Guadalupe, et al.
Publicado: (2023)

Efficacy of the Benznidazole+Posaconazole combination therapy in parasitemia reduction: An experimental murine model of acute Chagas
por: Echeverría, Luis Eduardo, et al.
Publicado: (2020)

Genetic polymorphism of Trypanosoma cruzi bloodstream populations in adult chronic indeterminate Chagas disease patients from the E1224 clinical trial
por: Ramírez, Juan Carlos, et al.
Publicado: (2021)

Systemic insecticide treatment of the canine reservoir of Trypanosoma cruzi induces high levels of lethality in Triatoma infestans, a principal vector of Chagas disease
por: Loza, Ariel, et al.
Publicado: (2017)

Improved DNA extraction technique from clot for the diagnosis of Chagas disease
por: Mayta, Holger, et al.
Publicado: (2019)

Deep Sequencing of the Trypanosoma cruzi GP63 Surface Proteases Reveals Diversity and Diversifying Selection among Chronic and Congenital Chagas Disease Patients
por: Llewellyn, Martin S., et al.
Publicado: (2015)

Achievements and Challenges upon the Implementation of a Program for National Control of Congenital Chagas in Bolivia: Results 2004–2009
por: Alonso-Vega, Cristina, et al.
Publicado: (2013)

Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States
por: Irish, Amanda, et al.
Publicado: (2022)

Chagas Cardiomyopathy in the Context of the Chronic Disease Transition
por: Hidron, Alicia I., et al.
Publicado: (2010)

Parasitemia Levels in Trypanosoma cruzi Infection in Spain, an Area Where the Disease Is Not Endemic: Trends by Different Molecular Approaches
por: Flores-Chavez, Maria D., et al.
Publicado: (2022)

Unconventional Approaches to Direct Detection of Borreliosis and Other Tick Borne Illnesses: A Path Forward
por: Liotta, Lance, et al.
Publicado: (2021)

Hemi-Nested PCR and RFLP Methodologies for Identifying Blood Meals of the Chagas Disease Vector, Triatoma infestans
por: Roellig, Dawn M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mgqg4g9rf26an3rphtcvo13de0